XenoTalks™ Seminar Series: The Importance of ADME and DDI in Drug Development
XenoTech, THE ADME Experts, is proud to present our 2022 seminar series! After having to put our events on hold during 2020-2021, we’re excited to start up again with free in-person &/or virtual events. Please let us know asap whether you would prefer in-person &/or online events to give us an idea of how best to proceed. If you would be open to in-person events, please note where you would like us to hold events.
There are no remaining dates/locations scheduled for 2022. However, anywhere in North America, Europe & beyond is a possibility in 2023!
Request a Location or Topic and Receive Details Once Available
Event Details:
These fully interactive events provide in-depth presentations from industry experts along with free food and drinks and good conversations. We will cover various topics around pharmaceutical preclinical testing with specifics on how to effectively move compounds through the development pipeline.
Request a Seminar Location or Topic
Previous XenoTalks™ Presentation Topics:
Previous topics and presenters included Dr. Griff Humphreys on “Metabolism Studies to Support Predictive Toxicology and Safety Programs,” Andrea Wolff, XenoTech Director of Services Logistics, on “Are We Finally Harmonized? Highlight Comparison Between the Finalized US FDA (2020), Japan PMDA (2018), and EMA (2013) In Vitro DDI Guidance Documents,” Dr. Larry Wienkers on “Application of Diagnostic Experiments to Elucidate the Mechanism Accounting for Irreversible Inhibition of Cytochrome P450 Enzymes,” Dr. Maciej Czerwinski on “Regulatory and Technical Aspects of Investigating the Role of Non-CYP Mediated Metabolism,” Greg Loewen on “In Vitro Enzyme Inhibition Studies and Timing of In Vitro DDI” and much more.
Watch the 2019 Commencement Keynote Presentation:
